A randomized, double-blind, placebo-controlled study of monoclonal Anti-IgE antibody Omalizumab in the management of pruritus in chronic spontaneous urticaria in the pediatric population

被引：0
|
作者：
Mitra, B. [1 ]
机构：
[1] Base Hosp Delhi Cantt, Dept Pediat, New Delhi, India
来源：
EXPERIMENTAL DERMATOLOGY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
6
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [31] Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome
    Glaze, Daniel G.
    Neul, Jeffrey L.
    Kaufmann, Walter E.
    Berry-Kravis, Elizabeth
    Condon, Sean
    Stoms, George
    Oosterholt, Sean
    Della Pasqua, Oscar
    Glass, Larry
    Jones, Nancy E.
    Percy, Alan K.
    Beisang, Arthur
    Benke, Timothy
    Feyma, Timothy
    Heydemann, Peter
    Jones, Mary
    Marsh, Eric D.
    Peters, Sarika
    Peterson, Myron Skip
    Sahin, Mustafa
    Skinner, Steve
    Standridge, Shannon
    NEUROLOGY, 2019, 92 (16) : E1912 - E1925
  • [32] EFFICACY AND SAFETY OF OMALIZUMAB IN H1-ANTIHISTAMINE-REFRACTORY CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA: RESULTS OF A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Saini, S. S.
    Bindslev-Jensen, C.
    Maurer, M.
    Grob, J. J.
    Baskan, E. Bulbul
    Bradley, M. S.
    Georgiou, P.
    Alpan, O.
    Spector, S.
    Rosen, K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A18 - A18
  • [33] Galcanezumab in chronic migraine The randomized, double-blind, placebo-controlled REGAIN study
    Detke, Holland C.
    Goadsby, Peter J.
    Wang, Shufang
    Friedman, Deborah I.
    Selzler, Katherine J.
    Aurora, Sheena K.
    NEUROLOGY, 2018, 91 (24) : E2211 - E2221
  • [34] A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria
    Sharma, Vinod K.
    Singh, Saurabh
    Ramam, M.
    Kumawat, Mahesh
    Kumar, Rakesh
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2014, 80 (02): : 122 - 128
  • [35] Randomized, Double-blind, Placebo-controlled Trial of ALD403 (eptinezumab), an Anti-CGRP Monoclonal Antibody for the Prevention of Chronic Migraine
    Smith, J.
    Dodick, D. W.
    Goadsby, P. J.
    Silberstein, S. D.
    Lipton, R. B.
    Hirman, J.
    HEADACHE, 2017, 57 : 130 - 130
  • [36] A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis
    Bissonnette, Robert
    Papp, Kim
    Maari, Catherine
    Yao, Yihong
    Robbie, Gabriel
    White, Wendy I.
    Le, Chenxiong
    White, Barbara
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : 427 - 436
  • [37] ACRIVASTINE VERSUS CLEMASTINE IN THE TREATMENT OF CHRONIC IDIOPATHIC URTICARIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    JUHLIN, L
    GIBSON, JR
    HARVEY, SG
    HUSON, LW
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1987, 26 (10) : 653 - 654
  • [38] Safety and efficacy of cetirizine versus cetirizine plus ranitidine in chronic urticaria: Double-blind randomized placebo-controlled study
    Guevara-Gutierrez, Elizabeth
    Bonilla-Lopez, Sonia
    Hernandez-Arana, Socorro
    Tlacuilo-Parra, Alberto
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (06) : 548 - 550
  • [39] Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study
    Grob, J. J.
    Auquier, P.
    Dreyfus, I.
    Ortonne, J. P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (01) : 87 - 93
  • [40] Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study
    Kaplan, AP
    Spector, SL
    Meeves, S
    Liao, YN
    Varghese, ST
    Georges, G
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 94 (06) : 662 - 669
12345